financeneutral
Viemed Healthcare: A Rising Star in Home Care Stocks
Tuesday, March 17, 2026
Viemed Healthcare, ticker VMD, has climbed to a new two‑year peak at nearly $10 per share, marking a 30% rise over the past year. The company’s market cap sits around $355 million, and it offers home medical equipment along with respiratory services through its Sleep Management and Home Sleep Delivered subsidiaries.
Technical Overview
- Barchart: 100 % “Buy” status, high weighted alpha of +57.28, and an active trend‑seeker “Buy” indicator.
- 50‑day moving average: $8.12
- Current price: $9.96
Fundamental Highlights
| Metric | Value |
|---|---|
| Revenue growth (this year) | 16.7 % |
| Revenue growth (next year) | 15 % |
| Trailing P/E | ~25 |
| Morningstar fair value estimate | $10.92 (≈15 % discount) |
Analyst Sentiment
- Wall Street: 1 “Strong Buy”, 1 “Hold”
- CFRA: Strong purchase recommendation
- Retail:
- 16 Motley Fool investors expect outperformance
- 2,940 Seeking Alpha members give a “Buy”
Risk & Considerations
- Short interest: < 1 % of float
- Rapid price gains can lead to volatility and speculation.
- A disciplined approach—diversification, stop‑loss rules, and alignment with personal risk tolerance—is essential before adding VMD to a portfolio.
Bottom Line
Viemed Healthcare presents an attractive mix of growth potential and solid fundamentals, but careful risk management remains key for anyone considering this opportunity.
Actions
flag content
